Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Imapextide (MBX 1416), long-acting GLP-1 receptor antagonist for post-bariatric hypoglycemia (PBH)
Physicians eye long-term data, but early results appear powerful
In the context of simultaneous GLP-1 activation and caloric restriction, GIP might help mobilize fat stores more effectively or prevent metabolic adaptations that normally fight weight loss
Medicare GLP-1 Bridge program FAQs Does Medicare cover GLP-1s
The STEP trial data is clear on this point
US$ 28.57
US$ 25.35
US$ 27.51
US$ 24.92
US$ 20.98
US$ 23.68
US$ 24.58
US$ 24.60
US$ 24.86
US$ 22.46
US$ 20.75
US$ 20.19
US$ 26.76
